Lai Meiyao Pharmaceutical: Indirect major shareholder ownership structure planned to change

Leumi Pharmaceuticals Announcement: Recently, the controlling shareholder of the company, Zhongheng Group, received a notice from its indirect controlling shareholder, Guangtou Group, informing them that there will be changes in the equity structure of Guangtou Group. Guangtou Group received a notice from the Guangxi State-owned Assets Supervision and Administration Commission, planning to transfer the 33% equity held by Guangxi State-owned Assets Supervision and Administration Commission to Guangxi State-owned Assets Holding Group without any payment. After this transfer is completed, the controlling shareholder of the company will still be Zhongheng Group, and the actual controlling shareholder will still be the Guangxi State-owned Assets Supervision and Administration Commission. Guangxi State-owned Assets Holding Group will become a shareholder of Guangtou Group, holding 33% of its equity, while the Guangxi State-owned Assets Supervision and Administration Commission will remain the controlling shareholder of Guangtou Group, holding 67% of its equity. This change in the equity structure is the Guangxi State-owned Assets Supervision and Administration Commission's integration of the equity structure of the company's indirect controlling shareholder and will not have a substantial impact on the company's operations and production activities.